176 related articles for article (PubMed ID: 38252148)
1. FOXA2-initiated transcriptional activation of INHBA induced by methylmalonic acid promotes pancreatic neuroendocrine neoplasm progression.
Hu C; Ye M; Bai J; Liu P; Lu F; Chen J; Xu Y; Yan L; Yu P; Xiao Z; Gu D; Xu L; Tian Y; Tang Q
Cell Mol Life Sci; 2024 Jan; 81(1):50. PubMed ID: 38252148
[TBL] [Abstract][Full Text] [Related]
2. Serotonin immunoreactive pancreatic neuroendocrine neoplasm associated with main pancreatic duct dilation: a recognizable entity with excellent long-term outcome.
Dioguardi Burgio M; Cros J; Panvini N; Depoilly T; Couvelard A; Ruszniewski P; de Mestier L; Hentic O; Sauvanet A; Dokmak S; Faccinetto A; Ronot M; Vilgrain V
Eur Radiol; 2021 Nov; 31(11):8671-8681. PubMed ID: 33977308
[TBL] [Abstract][Full Text] [Related]
3. Inhibin β-A (INHBA) induces epithelial-mesenchymal transition and accelerates the motility of breast cancer cells by activating the TGF-β signaling pathway.
Yu Y; Wang W; Lu W; Chen W; Shang A
Bioengineered; 2021 Dec; 12(1):4681-4696. PubMed ID: 34346300
[TBL] [Abstract][Full Text] [Related]
4. Dual role of autotaxin as novel biomarker and therapeutic target in pancreatic neuroendocrine neoplasms.
Toyohara T; Yoshida M; Miyabe K; Hayashi K; Naitoh I; Kondo H; Hori Y; Kato A; Kachi K; Asano G; Sahashi H; Adachi A; Kuno K; Kito Y; Matsuo Y; Kataoka H
Cancer Sci; 2023 Dec; 114(12):4571-4582. PubMed ID: 37770812
[TBL] [Abstract][Full Text] [Related]
5. Inhibin βA is an independent prognostic factor that promotes invasion via Hippo signaling in non‑small cell lung cancer.
Zhang Y; Yan S; Li Y; Zhang J; Luo Y; Li P; Yang Y; Li Y; Huang Y; Wang E
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34505633
[TBL] [Abstract][Full Text] [Related]
6. Methylmalonic acid promotes colorectal cancer progression via activation of Wnt/β-catenin pathway mediated epithelial-mesenchymal transition.
Hu C; Ye M; Bai J; Liu P; Lu F; Chen J; Yu P; Chen T; Shi X; Tang Q
Cancer Cell Int; 2023 Jul; 23(1):131. PubMed ID: 37403090
[TBL] [Abstract][Full Text] [Related]
7. Inhibin subunit beta A promotes cell proliferation and metastasis of breast cancer through Wnt/β-catenin signaling pathway.
Xueqin T; Jinhong M; Yuping H
Bioengineered; 2021 Dec; 12(2):11567-11575. PubMed ID: 34889158
[TBL] [Abstract][Full Text] [Related]
8. Rb Loss and
Hijioka S; Hosoda W; Matsuo K; Ueno M; Furukawa M; Yoshitomi H; Kobayashi N; Ikeda M; Ito T; Nakamori S; Ishii H; Kodama Y; Morizane C; Okusaka T; Yanagimoto H; Notohara K; Taguchi H; Kitano M; Yane K; Maguchi H; Tsuchiya Y; Komoto I; Tanaka H; Tsuji A; Hashigo S; Kawaguchi Y; Mine T; Kanno A; Murohisa G; Miyabe K; Takagi T; Matayoshi N; Yoshida T; Hara K; Imamura M; Furuse J; Yatabe Y; Mizuno N
Clin Cancer Res; 2017 Aug; 23(16):4625-4632. PubMed ID: 28455360
[No Abstract] [Full Text] [Related]
9. EZH2 Inhibition as New Epigenetic Treatment Option for Pancreatic Neuroendocrine Neoplasms (PanNENs).
April-Monn SL; Andreasi V; Schiavo Lena M; Sadowski MC; Kim-Fuchs C; Buri MC; Ketkar A; Maire R; Di Domenico A; Schrader J; Muffatti F; Doglioni C; Partelli S; Falconi M; Perren A; Marinoni I
Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638497
[TBL] [Abstract][Full Text] [Related]
10. INHBA gene silencing inhibits gastric cancer cell migration and invasion by impeding activation of the TGF-β signaling pathway.
Chen ZL; Qin L; Peng XB; Hu Y; Liu B
J Cell Physiol; 2019 Aug; 234(10):18065-18074. PubMed ID: 30963572
[TBL] [Abstract][Full Text] [Related]
11. Utility of contrast-enhanced harmonic endoscopic ultrasonography for predicting the prognosis of pancreatic neuroendocrine neoplasms.
Ishikawa R; Kamata K; Hara A; Tanaka H; Okamoto A; Yamazaki T; Nakai A; Omoto S; Minaga K; Yamao K; Takenaka M; Minami Y; Watanabe T; Chiba Y; Chikugo T; Matsumoto I; Takeyama Y; Matsukubo Y; Hyodo T; Kudo M
Dig Endosc; 2021 Jul; 33(5):829-839. PubMed ID: 33020955
[TBL] [Abstract][Full Text] [Related]
12. Neoplastic Progression in Neuroendocrine Neoplasms of the Pancreas.
Luchini C; Scarpa A
Arch Pathol Lab Med; 2023 Mar; ():. PubMed ID: 36881771
[TBL] [Abstract][Full Text] [Related]
13. Chronological improvement of pancreatectomy for resectable but advanced pancreatic neuroendocrine neoplasms.
Takamoto T; Nara S; Ban D; Mizui T; Murase Y; Esaki M; Shimada K
Pancreatology; 2022 Dec; 22(8):1141-1147. PubMed ID: 36404199
[TBL] [Abstract][Full Text] [Related]
14. FOXA2 functions as a suppressor of tumor metastasis by inhibition of epithelial-to-mesenchymal transition in human lung cancers.
Tang Y; Shu G; Yuan X; Jing N; Song J
Cell Res; 2011 Feb; 21(2):316-26. PubMed ID: 20820189
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine differentiation in the 12T-10 transgenic prostate mouse model mimics endocrine differentiation of pancreatic beta cells.
Gupta A; Wang Y; Browne C; Kim S; Case T; Paul M; Wills ML; Matusik RJ
Prostate; 2008 Jan; 68(1):50-60. PubMed ID: 18004726
[TBL] [Abstract][Full Text] [Related]
16. FOXA2 attenuates the epithelial to mesenchymal transition by regulating the transcription of E-cadherin and ZEB2 in human breast cancer.
Zhang Z; Yang C; Gao W; Chen T; Qian T; Hu J; Tan Y
Cancer Lett; 2015 Jun; 361(2):240-50. PubMed ID: 25779673
[TBL] [Abstract][Full Text] [Related]
17. Invasion of ovarian cancer cells is induced byPITX2-mediated activation of TGF-β and Activin-A.
Basu M; Bhattacharya R; Ray U; Mukhopadhyay S; Chatterjee U; Roy SS
Mol Cancer; 2015 Aug; 14():162. PubMed ID: 26298390
[TBL] [Abstract][Full Text] [Related]
18. The Eighth Edition of the American Joint Committee on Cancer Distant Metastases Stage Classification for Metastatic Pancreatic Neuroendocrine Tumors Might Be Feasible for Metastatic Pancreatic Ductal Adenocarcinomas.
Wen J; Chen J; Liu D; Xu X; Fan M; Zhang Z
Neuroendocrinology; 2020; 110(5):364-376. PubMed ID: 31357196
[TBL] [Abstract][Full Text] [Related]
19. FOXA2 suppresses gallbladder carcinoma cell migration, invasion, and epithelial-mesenchymal transition by targeting SERPINB5.
Hong L; Chen M; Huang M; Chen W; Abudukeremu X; She F; Chen Y
Environ Toxicol; 2024 Feb; 39(2):708-722. PubMed ID: 37665156
[TBL] [Abstract][Full Text] [Related]
20. Transcriptomic and CRISPR/Cas9 technologies reveal FOXA2 as a tumor suppressor gene in pancreatic cancer.
Vorvis C; Hatziapostolou M; Mahurkar-Joshi S; Koutsioumpa M; Williams J; Donahue TR; Poultsides GA; Eibl G; Iliopoulos D
Am J Physiol Gastrointest Liver Physiol; 2016 Jun; 310(11):G1124-37. PubMed ID: 27151939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
